IP Library Granted Patent US 7,794,927
Granted Patent B2
US 7,794,927 · App. 11/556,216 · Granted Sep 14, 2010

Method for identifying agonists or antagonists of the G-protein coupled receptor mas-like 1

Assignee: Sanofi-Aventis Deutschland GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,794,927
App. No.
11/556,216
Granted
Sep 14, 2010
Kind
B2
Abstract

The invention relates to a method for identifying a compound which stimulates or attenuates the activity of the G protein-coupled receptor mas-like 1.

Claims (22)

1. A method for identifying an agonist of the G protein-coupled receptor mas-like 1 having the amino acid sequence of SEQ ID NO: 2 comprising the steps of:

a) providing at least one cell or membrane fraction of said cell which expresses said mas-like 1 receptor on its surface,

b) providing at least one candidate chemical compound;

c) providing at least one natural ligand of the GPCR mas-like 1 selected from the group consisting of substance P2-11 (SEQ ID NO:10), P4-11 (SEQ ID NO:11) and P1-9 (SEQ ID NO:12);

d) contacting the at least one cell or membrane fraction with the at least one natural ligand to form a mixture and measuring a first activation of the GPCR mas-like 1;

e) contacting the mixture with the at least one chemical compound;

f) measuring a second activation of the GPCR mas-like 1; and

g) comparing the first activation with the second activation,

such that the second activation is greater than the first activation is indicative that the at least one chemical compound is an agonist the GPCR mas-like 1.

2. The method of claim 1 wherein said cell is selected from a group consisting of: CHO cells, CHO K1 cells, and HEK cells.

3. The method of claim 1 , wherein the first and second activations are measured by measuring [Ca 2+ ] in the mixture.

4. A method for identifying an antagonist of the G protein-coupled receptor mas-like 1 having the amino acid sequence of SEQ ID NO: 2 comprising the steps of:

a) providing at least one cell or membrane fraction of said cell which expresses said mas-like 1 receptor on its surface,

b) providing at least one candidate chemical compound;

c) providing at least one natural ligand of the GPCR mas-like 1 selected from the group consisting of substance P2-11 (SEQ ID NO:10), P4-11 (SEQ ID NO:11) and P1-9 (SEQ ID NO:12);

d) contacting the at least one cell or membrane fraction with the at least one natural ligand to form a mixture and measuring a first activation of the mas-like 1 receptor;

e) contacting the mixture with the at least one chemical compound;

f) measuring a second activation of the mas-like 1 receptor; and

g) comparing the first activation with the second activation,

such that the second activation is less than the first activation is indicative that the at least one chemical compound is an antagonist the GPCR mas-like 1.

5. The method of claim 4 wherein said cell is selected from a group consisting of: CHO cells, CHO K1 cells, and HEK cells.

6. The method of claim 4 , wherein the first and second activations are measured by measuring [Ca 2+ ] in the mixture.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2010
From: KOSTENIS, EVI; GASSENHUBER, JOHANN
To: AVENTIS PHARMA DEUTSCHLAND GMBH
Reel/Frame 024510/0512 →
CHANGE OF NAME Recorded Jun 9, 2010
From: AVENTIS PHARMA DEUTSCHLAND GMBH
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 024510/0603 →
Priority Claims (1)
DE 102 25 443 · Jun 8, 2002 · national
Continuity (3)
Division 1045670000 · Jun 6, 2003
Provisional Application 6042298500 · Nov 1, 2002
Related Publication 20070259378A1 · Nov 8, 2007